Albertsons Companies, Inc. (ACI)
Consumer Defensive
- Fundamental
- 2
- Sentiment
- 2
- Technical
- 3
Do Nothing: fundamentalScore 2 and qualitativeScore 2 both fall below the required floor of 3, so no long entry is admissible regardless of the chart; the tape itself is a valid but extended short-term uptrend (price above SMA20/50/EMA9/EMA21, MACD 0.28/0.10/0.18 expanding, ADX 23.5) still capped by a falling SMA200 at 15.09, and neither a breakout stop above the running 13.74 high nor a pullback limit at the EMA21 12.50 shelf can be actioned while the override floors fail.
Company overview
Albertsons Companies, Inc. operates in the food and drug retail industry in the United States, offering grocery products, general merchandise, health and beauty care products, pharmacy services, and fuel. The company runs stores under various banners, including Albertsons, Safeway, and Vons, and also manages in-store pharmacies, coffee shops, and digital platforms.
Fundamental
weakAlbertsons shows statistical cheapness but faces declining sales, legal risks, and high leverage.
Cheap for a reason: Albertsons still throws off real cash (about $2.37B operating, roughly $507M free) and trades near 7x EV/EBITDA with a ~7.8% free-cash-flow yield and a 4.7% dividend, but FY2025 earnings were gutted by a $773.8M opioid settlement while the charge-free FY2026 interim periods show identical sales turning negative and segment EBITDA down 11%, leverage near 5x lease-adjusted, reported interest coverage below 1.0x, and three material legal outcomes landing within the next three weeks. Mixed-to-weak; not actionable.
Sentiment
weakSentiment is mildly negative with no positive catalysts and a moderate litigation overhang.
Dominant catalyst is the 2026-10-13 Q2 FY2026 print (announced), which in-window coverage scored net-negative - third consecutive quarter of negative identical sales, gross-margin compression and a paused outlook - reinforced by post-print BofA and JPMorgan downgrades and a consensus target sitting at the current price; the sentiment delta is determinate but essentially flat and mildly negative (baseline polarity ~ -0.05 -> scoring ~ -0.14). No severe flag fired (regulator_confirmed_count = 0, going concern negative), but a moderate red-flag cap applied for confirmed material litigation clustered inside the horizon (Washington opioid bench decision ~2026-11-05, Schutte FCA appeal, Kroger damages trial), and no market-rewarded bullish element exists to support a mixed read.
Technical
fairThe stock is in a short-term uptrend but remains below long-term resistance levels.
Chart quality 3/5 — constructive but not clean. ACI sits 10.4% above its SMA20 (12.20) and 9.8% above its SMA50 (12.27) after a ~24% six-week advance off the 10.86 July low; MACD is 0.28/0.10/0.18 (positive, above signal, histogram widening for six sessions), ADX14 23.46 is rising from 17.7 with price above every short/mid MA, and volume has confirmed the thrust. Against that: RSI14 70.26 and Williams %R -11.49 are short-term overbought, today's push to 13.74 faded to a 13.47 close (essentially at the daily VWAP 13.465), and price is still 10.7% below a falling SMA200 (15.09) with the SMA50 underneath it, so the primary downtrend is not reclaimed. The score grades the tape only; the trade is blocked by the override pillars, not by the chart.
You’re looking at 2026-10-20 — more than 2 trading days ago.
Subscribers saw this then, and see today’s score, verdict and trade plan now.
More Consumer Defensive
Not financial advice. For informational and educational purposes only.

